Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

HCC Profiles

Hepatocellular carcinoma (HCC) requires thorough evaluation of the tumor stage to ensure precise prognosis and clear treatment recommendations, including consideration of liver transplantation. To achieve this goal, patient assessment must be based on both radiological and clinical parameters. The new HCC staging support in mint Lesion™ 3.0 therefore allows to easily capture a number of relevant imaging parameters (e.g. size, number, vascular invasion) and clinical data (e.g. Child-Pugh score and Performance Status). Based on these parameters, mint Lesion™ 3.0 automatically derives BCLC and TNM staging as well as liver transplantation recommendations according to Milan or UCSF criteria.

 

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

New Technique Speeds Up Whole-Body MRI for Children Without Sacrificing Image Quality, Study Finds

As we mark Childhood Cancer Awareness Month, we would like to highlight the progress achieved in the realm of cancer diagnostics. A recent study led…